Erratum: Serine is a natural ligand and allosteric activator of pyruvate kinase M2 (Nature (2012) 491 (458-462) doi:10.1038/nature11540);Serine is a natural ligand and allosteric activator of pyruvate kinase M2

Nature

Volumn 491, Issue 7424, 2012, Pages 458-462

  Chaneton, Barbara ^a   Hillmann, Petra ^b   Zheng, Liang ^a   Martin, Agnès C L ^b   Maddocks, Oliver D K ^a   Chokkathukalam, Achuthanunni ^c   Coyle, Joseph E ^b   Jankevics, Andris ^c,d   Holding, Finn P ^b   Vousden, Karen H ^a   Frezza, Christian ^a,e   O'Reilly, Marc ^b   Gottlieb, Eyal ^a  

^a BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^b ASTEX PHARMACEUTICALS   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d UNIVERSITY OF GRONINGEN   (Netherlands)

^e HUTCHISON MRC RESEARCH CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON; GLUCOSE; LIGAND; PYRUVATE KINASE; PYRUVATE KINASE M2; SERINE; UNCLASSIFIED DRUG;

CANCER; ENZYME ACTIVITY; GENE EXPRESSION; GLUCOSE; LIGAND; MITOCHONDRION;

ALLOSTERISM; ARTICLE; BINDING KINETICS; BIOACCUMULATION; BIOSYNTHESIS; CELL PROLIFERATION; ENZYME ACTIVITY; ISOTHERMAL TITRATION CALORIMETRY; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; X RAY DIFFRACTION;

EID: 84869082905     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature12075     Document Type: Erratum

References (24)

1. Tennant, D. A., Duran, R. V. & Gottlieb, E. Targeting metabolic transformation for cancer therapy. Nature Rev. Cancer 10, 267-277 (2010).
2. Chaneton, B. & Gottlieb, E. Rocking cell metabolism: revised functions of the key glycolytic regulator PKM2 in cancer. Trends Biochem. Sci. 37, 309-316 (2012).
3. Christofk, H. R. et al. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 452, 230-233 (2008).
4. Altenberg, B. & Greulich, K. O. Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes. Genomics 84, 1014-1020 (2004).
5. Mazurek, S., Boschek, C. B., Hugo, F. & Eigenbrodt, E. Pyruvate kinase type M2and its role in tumor growth and spreading. Semin. Cancer Biol. 15, 300-308 (2005).
6. Yamada, K. & Noguchi, T. Nutrient and hormonal regulation of pyruvate kinase gene expression. Biochem. J. 337, 1-11 (1999).
7. Possemato, R. et al. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature 476, 346-350 (2011).
8. Locasale, J. W. et al. Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. Nature Genet. 43, 869-874 (2011).
9. Pollari, S. et al. Enhanced serine production by bonemetastatic breast cancer cells stimulates osteoclastogenesis. Breast Cancer Res. Treat. 125, 421-430 (2011).
10. Vander Heiden, M. G. et al. Evidence for an alternative glycolytic pathway in rapidly proliferating cells. Science 329, 1492-1499 (2010).
11. Dombrauckas, J. D., Santarsiero, B. D. & Mesecar, A. D. Structural basis for tumor pyruvate kinase M2 allosteric regulation and catalysis. Biochemistry 44, 9417-9429 (2005).
12. Hitosugi, T. et al. Tyrosine phosphorylation inhibits PKM2to promote the Warburg effect and tumor growth. Sci. Signal. 2, ra73 (2009).
13. Christofk, H. R., Vander Heiden, M. G., Wu, N., Asara, J. M. & Cantley, L. C. Pyruvate kinase M2 is a phosphotyrosine-binding protein. Nature 452, 181-186 (2008).
14. Ashizawa, K., Willingham, M. C., Liang, C. M. & Cheng, S. Y. In vivo regulation of monomer-tetramer conversion of pyruvate kinase subtype M2 by glucose is mediatedviafructose1, 6-bisphosphate. J. Biol.Chem.266, 16842-16846(1991).
15. Spellman, C. M. & Fottrell, P. F. Similarities between pyruvate kinase from human placenta and tumours. FEBS Lett. 37, 281-284 (1973).
16. Eigenbrodt, E., Leib, S., Kramer, W., Friis, R. R. & Schoner, W. Structural and kinetic differences between the M2 type pyruvate kinases from lung and various tumors. Biomed. Biochim. Acta 42, S278-S282 (1983).
17. Ye, J. et al. Pyruvate kinase M2 promotes de novo serine synthesis to sustain mTORC1 activity and cell proliferation. Proc. Natl Acad. Sci. USA 109, 6904-6909 (2012).
18. Davies, T. G. & Tickle, I. J. Fragment screening using X-ray crystallography. Top. Curr. Chem. 317, 33-59 (2012).
19. Allali-Hassani, A. et al. A survey of proteins encoded by non-synonymous single nucleotide polymorphisms reveals a significant fraction with altered stability and activity. Biochem. J. 424, 15-26 (2009).
20. Medina, M. A., Marquez, J. & Nunez de Castro, I. Interchange of amino acids between tumor and host. Biochem. Med. Metab. Biol. 48, 1-7 (1992).
21. Márquez, J., Sanchez-Jimenez, F., Medina, M. A., Quesada, A. R. & Nunez de Castro, I. Nitrogen metabolism in tumor bearing mice. Arch. Biochem. Biophys. 268, 667-675 (1989).
22. Mattevi, A., Bolognesi, M. & Valentini, G.The allosteric regulationof pyruvate kinase. FEBS Lett. 389, 15-19 (1996).
23. Anastasiou, D. et al. Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses. Science 334, 1278-1283 (2011).
24. de Koning, T. J. et al. L-serine in disease and development. Biochem. J. 371, 653-661 (2003).